Successful Stocks

Company

Buy Price

Buy Date

Sell Price

Sell Date

Buy Reason

Cera Sanitaryware

170

Apr 2011

750

Feb 2014

Low PE, Good Growth, Brand Name

Wimplast

100

May 2012

850

Mar 2016

Low PE, Good Growth, Brand Name

Bayer Cropscience

950

Aug 2012

4100

Jan 2020

MNC Quality Company, PE of 20, Low penetration of agro inputs

Bajaj Finance

150

Feb 2014

2000

Apr 2020

Brand Name, Growth, PE of 10

Ipca Lab

700

July 2015

Holding

Little USA business and hence no FDA threat

TCI

40

Nov 2012

Holding

PE of 5, Growth, GST can be good for logistics

TCI Express

Demerged   from TCI

Holding

Same as above

Vaibhav Global

670

Apr 2019

Holding

PE of 14, Revenue from web increasing, Good ROE, ROCE, Opportunity Size Large

Laurus

100

Jun 2020

Holding

Stock available at forward PE of 12



Learnings:

  • Buy stocks trading at lower Price earnings multiple.
  • Buy companies which have shown growth in the past and are expected to continue that.
  • Sometimes companies can be ignored by investors due to a troubled past but the company might have learned its mistake and may have solved it and now are in growth trajectory. Such companies may be available cheap due to investor reluctance to buy them due to their past.
  • Even if the stock looks expensive, if the forward PE is low then still those stocks can deliver multifold returns.
  • If you sell in desperation then almost always you will sell cheap.

Popular posts from this blog

Uber like Aggregation Business

Image
Company is an aggregator which is similar to business models like Uber & OYO Rooms. The company has the platform which is much more efficient than the brick & mortar business model. Existing brick & mortar business is capital intensive, while the platform that the company has is negative working capital business. Hence this industry is ripe for getting disrupted. The company has tie-up with major e-commerce players like Amazon, Flipkart, etc. Recently company has expanded its capacity and hence the growth from here on can be steep.
Read more

Pharmaceutical CDMO Company

Image
A CDMO business is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing. This allows major pharmaceutical companies to outsource those aspects of the business, which can help with scalability or can allow the major company to focus on drug discovery and drug marketing instead. Big Pharma companies are increasingly trying to develop alternative options for the US and Europe (given the high cost of manufacturing) and China (given the unpredictability associated with it). Management Commentary: "W e see several tailwinds in our business and as we start getting our new capacity on-stream, we expect revenues and profitability to grow faster in next several years. Our strong customer relations, new business opportunities as well as healthy product pipeline will enable us to renew our growth trajectory over the medium to long term." The company is into pharmace
Read more

Stock for Short Term Gain of 30% - Free Stock

Image
The company has market cap of 1200 crores out of which 500 crores is cash and 0 debt. You are therefore getting this company for just 700 crores of enterprise value. Profits for this year will be at least 120 crores. Return on Capital Employed is 25%. The company is expected to come out with very good results for December quarter. Due to which in next 3-4 months we expect this stock to give 30% returns from the current level. Also there is a possibility of special dividend for this FY 2021 which can be about 10% of the current stock price. Loading…
Read more